# Effect of Chronic Incretin-based Therapy in Cystic Fibrosis

> **NCT01879228** · NA · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 26 (actual)

## Conditions studied

- Cystic Fibrosis
- Pancreatic Insufficiency

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01879228
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2019-12
- **Final completion:** 2020-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2022-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01879228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01879228, "Effect of Chronic Incretin-based Therapy in Cystic Fibrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01879228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*